Chimeric antigen receptor (CAR) targeting epidermal growth factor receptor (EGFR), CAR-T cells targeting EGFR, preparation method of CAR-T cells, and application of CAR and CAR-T cells

A chimeric antigen receptor and targeting technology, applied in the field of medical biology, can solve the problems of lack of relevant research and limitations of various EGFR-positive solid tumors, and achieve the effects of wide application range, high-efficiency transfer, and strong affinity activity

Inactive Publication Date: 2019-12-03
SHENZHEN BINDEBIOTECH CO LTD
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current application of CART technology is still limited to hematological tumors, and there is no relevant research on the application of various EGFR-positive solid tumors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric antigen receptor (CAR) targeting epidermal growth factor receptor (EGFR), CAR-T cells targeting EGFR, preparation method of CAR-T cells, and application of CAR and CAR-T cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] A method for preparing chimeric antigen receptor T cells targeting EGFR, comprising the following steps:

[0054] (1) Prepare the gene sequence of chimeric antigen receptor CAR-EGFR targeting EGFR

[0055] The coding gene sequence of the chimeric antigen receptor CAR-EGFR targeting EGFR is prepared by PCR, and the coding gene of the CAR-EGFR includes the nucleotide sequence shown in SEQ ID NO: 3;

[0056] (2) Construction of pWPXLd-CAR-EGFR recombinant plasmid

[0057] The gene encoding CAR-EGFR was inserted between the BamHI and EcoRI restriction sites of the pWPXLD vector, and behind the EF1α of the pWPXLD vector, EF1α was used as the promoter. When the CAR-EGFR coding gene is inserted into the pWPXLD vector, a start codon (such as ATG) is added to the 5' end of the CAR-EGFR coding gene to connect to the BamHI restriction site in the pWPXLD vector, and the 3' end is also A stop codon (such as TAA) is added to connect with the EcoRI restriction site in the pWPXLD vec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a chimeric antigen receptor (CAR) CAR-EGFR targeting an epidermal growth factor receptor (EGFR). The CAR-EGFR comprises an amino acid sequence shown as SEQ ID NO:1. The invention further provides CAR-T cells comprising the CAR-EGFR. The CAR-EGFR targeting the EGFR can specifically target EGFR positive tumor cells, activates the T cells to play a cellular immune role, efficiently and specifically kills the EGFR positive tumor cells, has long-lasting cellular vitality and lethality, and does not damage normal cells. The invention further provides a preparation method and application of the CAR-T cells targeting the EGFR.

Description

technical field [0001] The invention relates to the field of medical biology, in particular to a chimeric antigen receptor targeting EGFR, a chimeric antigen receptor T cell and a preparation method and application thereof. Background technique [0002] Cancer prevention and treatment is difficult and the disease burden is heavy, and it has become one of the major public health problems that seriously endanger human health. Epidermal growth factor receptor (EGFR) is a receptor for epidermal growth factor (EGF) cell proliferation and signal transduction, and belongs to the tyrosine kinase type I receptor subfamily. Studies have shown that there are high or abnormal expressions of EGFR in many solid tumors. EGFR is related to tumor cell proliferation, angiogenesis, tumor invasion, metastasis and inhibition of apoptosis. Therefore, in tumor therapy, EGFR can become a very important drug target. [0003] Chimeric Antigen Receptor–Modified T Cells (CAR-T), as one of the latest...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/867C12N5/10A61K35/17A61P35/00
CPCA61K35/17A61P35/00C07K14/7051C07K14/70578C07K16/2863C07K2319/00C07K2319/02C07K2319/33C07K2319/74C12N5/0636C12N15/86C12N2510/00C12N2740/15043C12N2800/107
Inventor 万晓春刘绿艳唐超李欣
Owner SHENZHEN BINDEBIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap